Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
54
datasets available to search
ShareScore release 0.9.0
Dataset results
54 results for “2992”
LUX-Lung 4: BIBW 2992 (Afatinib) Phase I Trial in Advanced Non Small Cell Lung Cancer Patients & Phase II Trial in Non Small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib
ClinicalTrials.gov study NCT00711594. IPD Sharing: Not stated. Countries: 1. Publications: 2.
BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation
ClinicalTrials.gov study NCT00949650. IPD Sharing: Not stated. Countries: 25. Publications: 9.
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
ClinicalTrials.gov study NCT01125566. IPD Sharing: Not stated. Countries: 38. Publications: 1.
Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform
ClinicalTrials.gov study NCT00977431. IPD Sharing: Not stated. Countries: 1. Publications: 1.
BIBW 2992 as add-on to Gem/Cis in Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT01679405. IPD Sharing: NO. Countries: 1. Publications: 1.
BIBW 2992 (Afatinib) in Combination With Pemetrexed in Advanced Solid Tumours
ClinicalTrials.gov study NCT01169675. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase I Dose Escalation Study of Concomitant BIBF 1120 and BIBW 2992 in Patients With Advanced Solid Tumours.
ClinicalTrials.gov study NCT00998296. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Afatinib (BIBW 2992) in Advanced Non-Small Cell Lung Cancer Patients With EGFR Mutation
ClinicalTrials.gov study NCT01953913. IPD Sharing: Not stated. Countries: 5. Publications: 2.
LUX Lung 2 Phase II Single Arm BIBW 2992 "Afatinib" in NSCLC With EGFR Activating Mutations
ClinicalTrials.gov study NCT00525148. IPD Sharing: Not stated. Countries: 2. Publications: 2.
An Open Label Phase I Dose Escalation Trial of Intravenous BI 6727 (Volasertib)in Combination With Oral BIBW 2992 (Afatinib) in Patients With Advanced Solid Tumours
ClinicalTrials.gov study NCT01206816. IPD Sharing: Not stated. Countries: 1. Publications: 1.
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
ClinicalTrials.gov study NCT01345669. IPD Sharing: Not stated. Countries: 29. Publications: 2.
Trial of Continuous Once Daily Oral Treatment Using BIBW 2992 (Afatinib) Plus Sirolimus (Rapamune®) in Patients With Non-small Cell Lung Cancer Harbouring an EGFR Mutation and/or Disease Progression F
ClinicalTrials.gov study NCT00993499. IPD Sharing: Not stated. Countries: 1. Publications: 1.
BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1)
ClinicalTrials.gov study NCT00656136. IPD Sharing: Not stated. Countries: 15. Publications: 1.
Single-arm Trial of BIBW 2992 (Afatinib) in Demographically and Genotypically Selected NSCLC Patients
ClinicalTrials.gov study NCT00730925. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Trial Exploring Afatinib (BIBW 2992) + Paclitaxel (Part A), Afatinib + Paclitaxel + Bevacizumab (Part B), Afatinib + Carboplatin (Part C) and Afatinib+ Paclitaxel +Carboplatin(Part D) in Patients With
ClinicalTrials.gov study NCT00809133. IPD Sharing: Not stated. Countries: 1. Publications: 2.
LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy
ClinicalTrials.gov study NCT01523587. IPD Sharing: Not stated. Countries: 23. Publications: 4.
BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT01121393. IPD Sharing: Not stated. Countries: 3. Publications: 7.
A Phase II Trial of Afatinib(BIBW 2992) in Third-line Treatment for Patients With Stage IIIB/IV Adenocarcinoma of the Lung Harbouring Wild-type Epidermal Growth Factor Receptor[EGFR]
ClinicalTrials.gov study NCT01003899. IPD Sharing: Not stated. Countries: 1. Publications: 1.
BIBW 2992 (Afatinib) in Head & Neck Cancer
ClinicalTrials.gov study NCT00514943. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Trial of Afatinib (BIBW 2992) + Cetuximab in Advanced Solid Tumours
ClinicalTrials.gov study NCT02020577. IPD Sharing: Not stated. Countries: 2. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.